ボツリヌス毒素の世界市場レポート 2025年

ボツリヌス毒素の市場規模は、今後数年間で力強い成長が見込まれます。2029年には115億7,000万米ドルに成長し、CAGRは9.6%となります。予測期間の成長は、美容医療市場の拡大、製剤とデリバリーの進歩、治療用途の多様化、世界の高齢化、新興市場における需要の高まり、患者の意識と受容の高まり、世界の市場の拡大などに起因すると考えられます。予測期間における主な動向としては、戦略的提携、個別化医療や精密医療へのアプローチ、新たな適応症に対する規制当局の承認、製品のイノベーションなどが挙げられます。

美容施術に対する需要の高まりが、今後数年間のボツリヌス毒素市場の拡大を牽引すると予測されます。美容施術は、外科的または非外科的な、個人の外見の向上や改善を目的とした様々な美容治療や介入を包含します。ボツリヌス毒素は、対象となる筋肉を弛緩させ、シワや小ジワを目立たなくするために、これらの処置に利用されます。例えば、2024年8月、米国最大の医学図書館である米国国立医学図書館（NLM）は、最新の予測によると、2023年の世界の増加率は3.4％で、形成外科医による美容整形手術と非外科的処置は3,490万件にのぼると予測しています。非外科的手術は1,910万件以上、外科的手術は1,580万件以上が世界中で実施されました。美容整形手術は過去10年間に徐々に増加し、2021年以降は顕著に加速しています。過去4年間だけでも、施術総数は40％増加しています。したがって、ボツリヌス毒素市場は美容整形に対する需要の高まりにより成長を遂げています。

世界の高齢化人口の急増は、今後数年間におけるボツリヌス毒素市場の拡大を促進すると予測されています。高齢化」とは、社会における高齢者の割合が増加することを特徴とする人口動態の変化を指します。ボツリヌス毒素は、しわや小じわに対処するために高齢化社会に広く受け入れられている人気のある低侵襲的なソリューションとして際立っており、顔の美観を高め、より若々しい外観を得るための非外科的な手段を提供しています。2022年10月に世界保健機関（WHO）が報告したように、世界の60歳以上の人口は急速な増加傾向にあり、2050年までに倍増し、推定21億人に達すると予測されています。このような人口動態の変化により、ボツリヌス毒素施術の需要が高まり、ボツリヌス毒素市場の成長を後押ししています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のボツリヌス毒素 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のボツリヌス毒素市場：成長率分析
• 世界のボツリヌス毒素市場の実績：規模と成長, 2019-2024
• 世界のボツリヌス毒素市場の予測：規模と成長, 2024-2029, 2034F
• 世界のボツリヌス毒素総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のボツリヌス毒素市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ボツリヌス毒素タイプA
• ボツリヌス毒素タイプB
• 世界のボツリヌス毒素市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 治療
• 美容
• 世界のボツリヌス毒素市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 専門クリニック
• 皮膚科クリニック
• その他のエンドユーザー
• 世界のボツリヌス毒素市場、タイプ別サブセグメンテーション：ボツリヌス毒素タイプA、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医療用途
• 美容用途
• 世界のボツリヌス毒素市場、タイプ別サブセグメンテーション：ボツリヌス毒素タイプB、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医療用途

第7章 地域別・国別分析

• 世界のボツリヌス毒素市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のボツリヌス毒素市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ボツリヌス毒素市場：競合情勢
• ボツリヌス毒素市場：企業プロファイル
  • Cigna Group Overview, Products and Services, Strategy and Financial Analysis
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Teijin Pharma Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Eisai Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Menarinin Group
• Ipsen Group
• Galderma S.A.
• Daewoong Pharmaceuticals Co. Ltd.
• Supernus Pharmaceuticals Inc.
• Merz Pharma GmbH & Co. KGaA
• Hugel Inc.
• Evolus Inc.
• Medytox Inc.
• Revance Therapeutics Inc.
• Sinclair Pharma
• US WorldMeds LLC
• Hugh Source International Ltd.
• MedivaPharma
• Wigmore Medical

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ボツリヌス毒素市場2029：新たな機会を提供する国
• ボツリヌス毒素市場2029：新たな機会を提供するセグメント
• ボツリヌス毒素市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Botulinum toxin, commonly known as Botox, is a neurotoxic protein produced by the bacterium Clostridium botulinum, recognized as one of the most potent toxins known to humans. Its applications span both medical and cosmetic purposes, encompassing the treatment of muscle spasms, reduction of wrinkles, management of excessive sweating, and addressing specific eye and bladder disorders.

The primary types of botulinum toxins include botulinum toxin type A and botulinum toxin type B. Botulinum toxin type A is a neurotoxic protein produced by Clostridium botulinum, widely utilized in various medical and cosmetic procedures. These applications extend to both therapeutic and aesthetic uses, with diverse end-users such as hospitals, specialty clinics, dermatology clinics, and others.

The botulinum toxins market research report is one of a series of new reports from The Business Research Company that provides botulinum toxins market statistics, including botulinum toxins industry global market size, regional shares, competitors with a botulinum toxins market share, detailed botulinum toxins market segments, market trends, and opportunities, and any further data you may need to thrive in the botulinum toxins industry. This botulinum toxins market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The botulinum toxin market size has grown strongly in recent years. It will grow from $7.32 billion in 2024 to $8.01 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to cosmetic applications, medical therapies, growth in aesthetic medicine, increased awareness and acceptance, research and development initiatives

The botulinum toxin market size is expected to see strong growth in the next few years. It will grow to $11.57 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to expanding aesthetic medicine market, advancements in formulations and delivery, diversification of therapeutic uses, global aging population, rising demand in emerging markets, growing patient awareness and acceptance, global market expansion. Major trends in the forecast period include strategic collaborations, personalized and precision medicine approaches, regulatory approvals for new indications, product innovations.

The growing demand for aesthetic procedures is anticipated to drive the expansion of the botulinum toxin market in the coming years. Aesthetic procedures encompass various cosmetic treatments and interventions aimed at enhancing or improving an individual's appearance, which can be either surgical or non-surgical. Botulinum toxin is utilized in these procedures to relax targeted muscles and diminish the visibility of wrinkles and fine lines. For example, in August 2024, the US National Library of Medicine (NLM), the largest medical library in the United States, predicted a 3.4% global increase for 2023, with 34.9 million cosmetic surgeries and nonsurgical procedures performed by plastic surgeons, according to the latest projections. More than 19.1 million nonsurgical procedures and over 15.8 million surgical operations were conducted worldwide. Aesthetic procedures have seen a gradual rise over the past decade, with a notable acceleration since 2021. In the last four years alone, there has been a 40% increase in the total number of procedures. Therefore, the botulinum toxin market is experiencing growth due to the heightened demand for cosmetic operations.

The burgeoning global aging population is anticipated to propel the expansion of the botulinum toxin market in the coming years. The term 'aging population' refers to a demographic shift characterized by a growing proportion of elderly individuals within a society. Botulinum toxin stands out as a popular and minimally invasive solution widely embraced by the aging population to address wrinkles and fine lines, offering a non-surgical avenue to enhance facial aesthetics and attain a more youthful appearance. As reported by the World Health Organization (WHO) in October 2022, the worldwide population aged 60 years and older is on a rapid growth trajectory, projected to double by 2050, reaching an estimated 2.1 billion individuals. This demographic shift towards an increasingly elderly population significantly contributes to the rising demand for botulinum toxin procedures, thereby propelling the growth of the botulinum toxin market.

Product innovation stands out as a prominent trend driving advancements in the botulinum toxin market, with companies actively pursuing innovative solutions to maintain their market positions. An illustration of this trend is evident in the developments by Evolus Inc., a US-based medical aesthetics company, which obtained approval from the Australian Therapeutic Goods Administration (TGA) in January 2023 for Nuceiva (prabotulinumtoxin A) in Australia. Nuceiva, containing botulinum toxin type A, is specifically designed for aesthetic purposes, aimed at temporarily enhancing the appearance of moderate glabellar lines in adult patients. The product functions by interrupting nerve impulses within facial muscles, inducing relaxation, and effectively smoothing wrinkles resulting from facial expressions such as squinting and frowning.

Leading companies in the botulinum toxin market are concentrating on creating innovative solutions, such as indigenous botulinum toxin injections, to enhance treatment efficacy, minimize side effects, and meet the increasing demand for both aesthetic and therapeutic applications. Indigenous botulinum toxin injection refers to formulations of botulinum toxin that are developed and manufactured locally, rather than being imported from international suppliers. For example, in December 2022, Gufic Biosciences, an India-based pharmaceutical company, launched Zarbot, which is India's first indigenous botulinum toxin injection (Botulinum Toxin Type A), in collaboration with US-based Prime Bio. Zarbot utilizes a purified HALL strain and a specialized formulation that improves stability, allowing for extended storage. It is designed to treat various neurological conditions and meets European and British pharmacopeial standards, ensuring its biological potency is comparable to that of international brands.

In August 2024, Crown Laboratories, Inc., a US-based pharmaceutical firm, acquired Revance Therapeutics, Inc., for $924 million. This acquisition aims to establish a leading global entity in the aesthetics and skincare sector by merging innovative products like Daxxify, thereby enhancing product offerings, accelerating growth, and expanding the provider network for both companies. Revance Therapeutics Inc. is a biotechnology company that provides a botulinum toxin product called DaxibotulinumtoxinA (DAXI).

Major companies operating in the botulinum toxin market include Cigna Group, Pfizer Inc., AbbVie Inc., Teijin Pharma Ltd., Eisai Co. Ltd., Menarinin Group, Ipsen Group, Galderma S.A., Daewoong Pharmaceuticals Co. Ltd., Supernus Pharmaceuticals Inc., Merz Pharma GmbH & Co. KGaA, Hugel Inc., Evolus Inc., Medytox Inc., Revance Therapeutics Inc., Sinclair Pharma, US WorldMeds LLC, Hugh Source International Ltd., MedivaPharma, Wigmore Medical, AesthetiCare, Lanzhou Institute of Biological Products Co Ltd., AestheticSource, Botox Cosmetic, Metabiologics Inc.

North America was the largest region in the botulinum toxin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the botulinum toxin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the botulinum toxin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The botulinum toxin market consists of sales of botulinum toxin C and botulinum toxin D and their related formulations. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Botulinum Toxin Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on botulinum toxin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for botulinum toxin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The botulinum toxin market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Botulinum Toxin Type A; Botulinum Toxin Type B
• 2) By Application: Therapeutics; Aesthetics
• 3) By End User: Hospitals; Specialty Clinics; Dermatology Clinics; Other End Users
• Subsegments:
• 1) By Botulinum Toxin Type A: Medical Applications; Aesthetic Applications
• 2) By Botulinum Toxin Type B: Medical Applications
• Companies Mentioned: Cigna Group; Pfizer Inc.; AbbVie Inc.; Teijin Pharma Ltd.; Eisai Co. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Botulinum Toxin Market Characteristics

3. Botulinum Toxin Market Trends And Strategies

4. Botulinum Toxin Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Botulinum Toxin Growth Analysis And Strategic Analysis Framework

• 5.1. Global Botulinum Toxin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Botulinum Toxin Market Growth Rate Analysis
• 5.4. Global Botulinum Toxin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Botulinum Toxin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Botulinum Toxin Total Addressable Market (TAM)

6. Botulinum Toxin Market Segmentation

• 6.1. Global Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Botulinum Toxin Type A
• Botulinum Toxin Type B
• 6.2. Global Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Therapeutics
• Aesthetics
• 6.3. Global Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Dermatology Clinics
• Other End Users
• 6.4. Global Botulinum Toxin Market, Sub-Segmentation Of Botulinum Toxin Type A, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medical Applications
• Aesthetic Applications
• 6.5. Global Botulinum Toxin Market, Sub-Segmentation Of Botulinum Toxin Type B, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medical Applications

7. Botulinum Toxin Market Regional And Country Analysis

• 7.1. Global Botulinum Toxin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Botulinum Toxin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Botulinum Toxin Market

• 8.1. Asia-Pacific Botulinum Toxin Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Botulinum Toxin Market

• 9.1. China Botulinum Toxin Market Overview
• 9.2. China Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Botulinum Toxin Market

• 10.1. India Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Botulinum Toxin Market

• 11.1. Japan Botulinum Toxin Market Overview
• 11.2. Japan Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Botulinum Toxin Market

• 12.1. Australia Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Botulinum Toxin Market

• 13.1. Indonesia Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Botulinum Toxin Market

• 14.1. South Korea Botulinum Toxin Market Overview
• 14.2. South Korea Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Botulinum Toxin Market

• 15.1. Western Europe Botulinum Toxin Market Overview
• 15.2. Western Europe Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Botulinum Toxin Market

• 16.1. UK Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Botulinum Toxin Market

• 17.1. Germany Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Botulinum Toxin Market

• 18.1. France Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Botulinum Toxin Market

• 19.1. Italy Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Botulinum Toxin Market

• 20.1. Spain Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Botulinum Toxin Market

• 21.1. Eastern Europe Botulinum Toxin Market Overview
• 21.2. Eastern Europe Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Botulinum Toxin Market

• 22.1. Russia Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Botulinum Toxin Market

• 23.1. North America Botulinum Toxin Market Overview
• 23.2. North America Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Botulinum Toxin Market

• 24.1. USA Botulinum Toxin Market Overview
• 24.2. USA Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Botulinum Toxin Market

• 25.1. Canada Botulinum Toxin Market Overview
• 25.2. Canada Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Botulinum Toxin Market

• 26.1. South America Botulinum Toxin Market Overview
• 26.2. South America Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Botulinum Toxin Market

• 27.1. Brazil Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Botulinum Toxin Market

• 28.1. Middle East Botulinum Toxin Market Overview
• 28.2. Middle East Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Botulinum Toxin Market

• 29.1. Africa Botulinum Toxin Market Overview
• 29.2. Africa Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Botulinum Toxin Market Competitive Landscape And Company Profiles

• 30.1. Botulinum Toxin Market Competitive Landscape
• 30.2. Botulinum Toxin Market Company Profiles
  • 30.2.1. Cigna Group Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Teijin Pharma Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Eisai Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Botulinum Toxin Market Other Major And Innovative Companies

• 31.1. Menarinin Group
• 31.2. Ipsen Group
• 31.3. Galderma S.A.
• 31.4. Daewoong Pharmaceuticals Co. Ltd.
• 31.5. Supernus Pharmaceuticals Inc.
• 31.6. Merz Pharma GmbH & Co. KGaA
• 31.7. Hugel Inc.
• 31.8. Evolus Inc.
• 31.9. Medytox Inc.
• 31.10. Revance Therapeutics Inc.
• 31.11. Sinclair Pharma
• 31.12. US WorldMeds LLC
• 31.13. Hugh Source International Ltd.
• 31.14. MedivaPharma
• 31.15. Wigmore Medical

32. Global Botulinum Toxin Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Botulinum Toxin Market

34. Recent Developments In The Botulinum Toxin Market

35. Botulinum Toxin Market High Potential Countries, Segments and Strategies

• 35.1 Botulinum Toxin Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Botulinum Toxin Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Botulinum Toxin Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer